At Marvin Pharma, we're dedicated to advancing public health by providing affordable, high‑quality medicines, with a special focus on combating malaria. We partner with global health leaders to ensure reliable supply chains and effective healthcare solutions.

Our Commitment to Malaria Control
Through global partnerships and local outreach, we distribute WHO-prequalified anti-malarial drugs to combat malaria in Uganda and across Africa.
Founded in 2017, Marvin Pharma Ltd is dedicated to advancing health and well-being through the provision of high-quality pharmaceutical solutions. Guided by a vision to be Uganda's leading pharmaceutical company, we combine scientific innovation with ethical business practices to create lasting impact in healthcare.
Marvin Pharma Ltd was incorporated in 2017 under the leadership of our Managing Director, Mr Mohammed Yousuf Pasha, who has rich experience of 20 years in the pharmaceutical industry in Uganda.
We aim to be established as the best pharmaceutical company in Uganda, recognized for expertise, innovation, and responsible entrepreneurship.
We are committed to advancing community health by focusing 65% of our resources on combating malaria with WHO-prequalified medicines while driving education, prevention, and awareness initiatives to foster a healthier, resilient society.








At Marvin Pharma, we leverage clinical research and scientific innovation to develop high-quality pharmaceutical solutions, focusing on malaria treatment, disease prevention, and improving overall public health outcomes. Our research is guided by real-world evidence, ensuring that our products are both effective and safe for the communities we serve.
